Literature DB >> 3019540

A nonviral, virus strain-specific antigen expressed on rat cells transformed by avian sarcoma virus.

E R Phillips, R J Ruch.   

Abstract

Five of six rat sarcomas, induced by the Schmidt-Ruppin (SR) strain of avian tumor virus, expressed a Mr 60,000 tumor cell surface antigen (TSA), immunoprecipitable from non-ionic detergent extracts. Expression of the antigen was exclusive to rat cells transformed by the SR virus strain. Moreover, expression of TSA appeared restricted by cell type. The five TSA-positive SR-transformed rat cell lines tested were apparently of fibroblastic origin, but cultured rat cerebral endothelial cells (RCE-T1), transformed by SR virus, showed no expression of TSA. However, the antigen emerged on cultured tumors obtained after histoincompatible transplantation of these cells into newborn rats of another strain (tumor digest cells). Investigation of TSA for immunological relationship to viral structural antigens and the src gene product indicated that the TSA is distinct from any of these and more probably derives from a virus-directed alteration in a host molecule.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019540

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Tumor immunity generated in the course of regression of v-src-induced sarcomas.

Authors:  T W Wisner; J M England; D Y Pan; A W Stoker; M S Halpern
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

2.  Separation of the tumor rejection antigen of Rous sarcoma virus-induced murine fibrosarcoma.

Authors:  T Suda; J Shimizu; Y Mizushima; H Fujiwara; T Hamaoka
Journal:  Jpn J Cancer Res       Date:  1988-03

3.  The tumor rejection antigen separated from Rous sarcoma virus-induced murine fibrosarcoma exhibits a molecular weight of approximately 60 kD but differs from functional pp60src.

Authors:  T Suda; J Shimizu; M Muramatsu; K Kimura; T O Yoshida; Y Fukami; H Fujiwara; T Hamaoka
Journal:  Jpn J Cancer Res       Date:  1989-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.